SKAN Group Future Growth
Future criteria checks 3/6
SKAN Group is forecast to grow earnings and revenue by 18.7% and 13.8% per annum respectively while EPS is expected to grow by 19.9% per annum.
Key information
18.7%
Earnings growth rate
19.9%
EPS growth rate
Life Sciences earnings growth | 21.7% |
Revenue growth rate | 13.8% |
Future return on equity | n/a |
Analyst coverage | Low |
Last updated | 17 May 2024 |
Recent future growth updates
No updates
Recent updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 505 | 50 | 48 | 82 | 2 |
12/31/2025 | 456 | 51 | 20 | 72 | 3 |
12/31/2024 | 386 | 40 | 18 | 58 | 3 |
12/31/2023 | 320 | 26 | -27 | 9 | N/A |
9/30/2023 | 308 | 27 | -10 | 19 | N/A |
6/30/2023 | 296 | 27 | 6 | 30 | N/A |
3/31/2023 | 286 | 23 | 19 | 46 | N/A |
12/31/2022 | 277 | 19 | 33 | 61 | N/A |
9/30/2022 | 265 | 13 | 14 | 49 | N/A |
6/30/2022 | 253 | 7 | -4 | 37 | N/A |
3/31/2022 | 244 | 9 | -18 | 24 | N/A |
12/31/2021 | 234 | 11 | -32 | 10 | N/A |
9/30/2021 | 217 | 7 | -18 | 15 | N/A |
6/30/2021 | 200 | 3 | -3 | 21 | N/A |
3/31/2021 | 196 | 4 | 2 | 22 | N/A |
12/31/2020 | 192 | 5 | 8 | 23 | N/A |
9/30/2020 | 150 | 12 | 1 | 12 | N/A |
6/30/2020 | 109 | 20 | -6 | 2 | N/A |
3/31/2020 | 64 | 19 | -2 | 2 | N/A |
12/31/2019 | 19 | 18 | 2 | 2 | N/A |
9/30/2019 | 13 | 12 | 2 | 2 | N/A |
6/30/2019 | 7 | 6 | 2 | 2 | N/A |
3/31/2019 | 7 | 6 | 2 | 2 | N/A |
12/31/2018 | 7 | 6 | 2 | 2 | N/A |
9/30/2018 | 11 | 8 | 2 | 2 | N/A |
6/30/2018 | 14 | 9 | 2 | 2 | N/A |
3/31/2018 | 17 | 12 | 2 | 2 | N/A |
12/31/2017 | 20 | 15 | 1 | 1 | N/A |
9/30/2017 | 17 | 13 | N/A | 1 | N/A |
6/30/2017 | 15 | 10 | N/A | 1 | N/A |
3/31/2017 | 19 | 13 | N/A | 1 | N/A |
12/31/2016 | 24 | 16 | N/A | 1 | N/A |
9/30/2016 | 23 | 15 | N/A | 1 | N/A |
6/30/2016 | 21 | 14 | N/A | 1 | N/A |
3/31/2016 | 22 | 16 | N/A | 1 | N/A |
12/31/2015 | 23 | 18 | N/A | 0 | N/A |
9/30/2015 | 22 | 19 | N/A | 0 | N/A |
6/30/2015 | 21 | 19 | N/A | 1 | N/A |
3/31/2015 | 13 | 12 | N/A | 0 | N/A |
12/31/2014 | 6 | 4 | N/A | 0 | N/A |
9/30/2014 | 6 | 5 | N/A | 0 | N/A |
6/30/2014 | 6 | 5 | N/A | 0 | N/A |
3/31/2014 | 4 | 4 | N/A | 0 | N/A |
12/31/2013 | 3 | 2 | N/A | 1 | N/A |
9/30/2013 | 4 | 3 | N/A | 1 | N/A |
6/30/2013 | 4 | 3 | N/A | 1 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 0SKN's forecast earnings growth (18.7% per year) is above the savings rate (1.8%).
Earnings vs Market: 0SKN's earnings (18.7% per year) are forecast to grow faster than the UK market (13.4% per year).
High Growth Earnings: 0SKN's earnings are forecast to grow, but not significantly.
Revenue vs Market: 0SKN's revenue (13.8% per year) is forecast to grow faster than the UK market (3.8% per year).
High Growth Revenue: 0SKN's revenue (13.8% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if 0SKN's Return on Equity is forecast to be high in 3 years time